BIOMAT Database Logo BIOMAT Database Logo

Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni). 1995

D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
Department of Clinical Sciences, Faculty of Medicine, University of Papua New Guinea.

The mechanisms of haemostatic failure were studied in 87 patients bitten by the Papuan taipan (Oxyuranus scutellatus canni). Eighty (92%) had evidence of a coagulopathy on laboratory testing; 36 (41.4%) developed spontaneous systemic bleeding, although this was rarely of clinical significance. Coagulation assays in 48 completely defibrinated patients showed marked reductions in factors V and VIII and reductions in factors II, IX, XI, XII and XIIIA. There was a reduction in plasminogen and alpha 2-antiplasmin levels and both total and cross-linked fibrin(ogen) degradation products (FDP) levels were elevated. The mean platelet count was initially decreased and fell further during admission. Similar but less severe changes were seen in patients who were mildly defibrinated. Following treatment with antivenom, fibrinogen levels rose rapidly and coagulability was restored within 6-12 h in 93% of patients. These abnormalities may be primarily attributable to the prothrombin activator present in taipan venom, but it is likely that other uncharacterized venom components contributed.

UI MeSH Term Description Entries
D010219 Papua New Guinea A country consisting of the eastern half of the island of New Guinea and adjacent islands, including New Britain, New Ireland, the Admiralty Islands, and New Hanover in the Bismarck Archipelago; Bougainville and Buka in the northern Solomon Islands; the D'Entrecasteaux and Trobriand Islands; Woodlark (Murua) Island; and the Louisiade Archipelago. It became independent on September 16, 1975. Formerly, the southern part was the Australian Territory of Papua, and the northern part was the UN Trust Territory of New Guinea, administered by Australia. They were administratively merged in 1949 and named Papua and New Guinea, and renamed Papua New Guinea in 1971. New Guinea, East,New Guinea, Papua
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D006474 Hemorrhagic Disorders Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS). Hemorrhagic Diathesis,Diatheses, Hemorrhagic,Diathesis, Hemorrhagic,Disorder, Hemorrhagic,Disorders, Hemorrhagic,Hemorrhagic Diatheses,Hemorrhagic Disorder
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000979 alpha-2-Antiplasmin A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin. alpha 2-Plasmin Inhibitor,Serpin F2,alpha(2)-Plasmin Inhibitor,alpha-2 Antiplasmin,alpha 2 Antiplasmin,alpha 2 Plasmin Inhibitor
D000997 Antivenins Antisera used to counteract poisoning by animal VENOMS, especially SNAKE VENOMS. Anti-Venin,Anti-Venom,Antivenin,Antivenom,Anti-Venins,Anti-Venoms,Antivenoms,Anti Venin,Anti Venins,Anti Venom,Anti Venoms

Related Publications

D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
A pharmacological examination of venom from the Papuan taipan (Oxyuranus scutellatus canni).
December 1999, Toxicon : official journal of the International Society on Toxinology,
D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
Isolation and pharmacological characterization of cannitoxin, a presynaptic neurotoxin from the venom of the Papuan Taipan (Oxyuranus scutellatus canni).
December 2005, The Journal of pharmacology and experimental therapeutics,
D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
Severe envenomation by the taipan (Oxyuranus scutellatus)
January 1996, The Medical journal of Australia,
D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
Variations in the pharmacological profile of post-synaptic neurotoxins isolated from the venoms of the Papuan (Oxyuranus scutellatus canni) and coastal (Oxyuranus scutellatus scutellatus) taipans.
March 2010, Neurotoxicology,
D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
Hypotensive and vascular relaxant effects of phospholipase A2 toxins from Papuan taipan (Oxyuranus scutellatus) venom.
January 2014, European journal of pharmacology,
D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
A case of acute hypogonadism following taipan (Oxyuranus scutellatus) envenomation.
June 2020, Toxicon : official journal of the International Society on Toxinology,
D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
In vivo and in vitro cardiovascular effects of Papuan taipan (Oxyuranus scutellatus) venom: Exploring "sudden collapse".
September 2012, Toxicology letters,
D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
Delayed Oral LY333013 Rescues Mice from Highly Neurotoxic, Lethal Doses of Papuan Taipan (Oxyuranus scutellatus) Venom.
September 2018, Toxins,
D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
Coastal taipan (Oxyuranus scutellatus) envenomation of a dog.
November 2015, Australian veterinary journal,
D G Lalloo, and A J Trevett, and D Owens, and J Minei, and S Naraqi, and A Saweri, and R A Hutton, and R D Theakston, and D A Warrell
The effects of antivenom on the in vitro neurotoxicity of venoms from the taipans Oxyuranus scutellatus, Oxyuranus microlepidotus and Oxyuranus scutellatus canni.
December 1999, Toxicon : official journal of the International Society on Toxinology,
Copied contents to your clipboard!